InsiderClue
Insiders · Profile

EVNIN LUKE

Director at Werewolf Therapeutics · Director at Pacira BioSciences · 10% owner at Altimmune. Filing since 7 Aug 2007. CIK 0001134657

HOWL Werewolf Therapeutics, Inc. Director · 89 trades PCRX Pacira BioSciences, Inc. Director · 17 trades ALT Altimmune, Inc. 10% owner · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
HOWL Werewolf Therapeutics, Inc.
7 Jul 2026
Director
Sold on a plan
107,429
$33.30K
100%
HOWL Werewolf Therapeutics, Inc.
6 Jul 2026
Director
Sold on a plan
35,770
$11.45K
25.0%
HOWL Werewolf Therapeutics, Inc.
29 Jun 2026
Director
Sold on a plan
157,084
$47.13K
52.3%
HOWL Werewolf Therapeutics, Inc.
9 Jun 2026
Director
Sold on a plan
76,928
$28.46K
20.4%
HOWL Werewolf Therapeutics, Inc.
8 Jun 2026
Director
Sold on a plan
60,547
$24.22K
13.8%
HOWL Werewolf Therapeutics, Inc.
5 Jun 2026
Director
Sold on a plan
24,946
$9.98K
5.4%
HOWL Werewolf Therapeutics, Inc.
4 Jun 2026
Director
Sold on a plan
20,072
$8.83K
4.2%
HOWL Werewolf Therapeutics, Inc.
3 Jun 2026
Director
Sold on a plan
29,749
$12.49K
5.8%
HOWL Werewolf Therapeutics, Inc.
2 Jun 2026
Director
Sold on a plan
29,595
$13.32K
5.5%
HOWL Werewolf Therapeutics, Inc.
1 Jun 2026
Director
Sold on a plan
80,459
$37.82K
12.9%
HOWL Werewolf Therapeutics, Inc.
29 May 2026
Director
Sold on a plan
32,556
$14.65K
5.0%
HOWL Werewolf Therapeutics, Inc.
28 May 2026
Director
Sold on a plan
27,698
$12.74K
4.1%
HOWL Werewolf Therapeutics, Inc.
27 May 2026
Director
Sold on a plan
80,852
$38.81K
10.6%
HOWL Werewolf Therapeutics, Inc.
26 May 2026
Director
Sold on a plan
67,950
$31.94K
8.2%
HOWL Werewolf Therapeutics, Inc.
22 May 2026
Director
Sold on a plan
87,425
$39.34K
9.5%
HOWL Werewolf Therapeutics, Inc.
21 May 2026
Director
Sold on a plan
36,387
$15.28K
3.8%
HOWL Werewolf Therapeutics, Inc.
20 May 2026
Director
Sold on a plan
85,895
$36.93K
8.2%
HOWL Werewolf Therapeutics, Inc.
19 May 2026
Director
Sold on a plan
62,970
$28.34K
5.7%
HOWL Werewolf Therapeutics, Inc.
18 May 2026
Director
Sold on a plan
22,184
$11.09K
2.0%
HOWL Werewolf Therapeutics, Inc.
13 May 2026
Director
Sold on a plan
44,679
$24.13K
3.8%
HOWL Werewolf Therapeutics, Inc.
12 May 2026
Director
Sold on a plan
67,885
$43.45K
5.5%
HOWL Werewolf Therapeutics, Inc.
11 May 2026
Director
Sold on a plan
33,948
$22.75K
2.7%
HOWL Werewolf Therapeutics, Inc.
8 May 2026
Director
Sold on a plan
305,741
$214.02K
19.4%
HOWL Werewolf Therapeutics, Inc.
7 May 2026
Director
Sold on a plan
79,086
$49.82K
4.8%
HOWL Werewolf Therapeutics, Inc.
6 May 2026
Director
Sold on a plan
14,635
$9.66K
0.9%
HOWL Werewolf Therapeutics, Inc.
5 May 2026
Director
Sold on a plan
6,860
$4.73K
0.4%
HOWL Werewolf Therapeutics, Inc.
4 May 2026
Director
Sold on a plan
47,963
$34.53K
2.8%
HOWL Werewolf Therapeutics, Inc.
1 May 2026
Director
Sold on a plan
58,394
$42.63K
3.3%
HOWL Werewolf Therapeutics, Inc.
30 Apr 2026
Director
Sold on a plan
168,262
$121.15K
8.6%
HOWL Werewolf Therapeutics, Inc.
29 Apr 2026
Director
Sold on a plan
56,559
$39.03K
2.8%
HOWL Werewolf Therapeutics, Inc.
28 Apr 2026
Director
Sold on a plan
95,412
$69.65K
4.5%
HOWL Werewolf Therapeutics, Inc.
27 Apr 2026
Director
Sold on a plan
53,940
$45.85K
2.5%
HOWL Werewolf Therapeutics, Inc.
16 Jan 2026
Director
Sold on a plan
38,782
$20.94K
1.8%
HOWL Werewolf Therapeutics, Inc.
15 Jan 2026
Director
Sold on a plan
37,413
$20.58K
1.7%
HOWL Werewolf Therapeutics, Inc.
14 Jan 2026
Director
Sold on a plan
30,616
$17.45K
1.4%
HOWL Werewolf Therapeutics, Inc.
13 Jan 2026
Director
Sold on a plan
43,198
$23.76K
1.9%
HOWL Werewolf Therapeutics, Inc.
12 Jan 2026
Director
Sold on a plan
58,980
$33.62K
2.5%
HOWL Werewolf Therapeutics, Inc.
9 Jan 2026
Director
Sold on a plan
24,678
$15.05K
1.0%
HOWL Werewolf Therapeutics, Inc.
8 Jan 2026
Director
Sold on a plan
7,716
$4.86K
0.3%
HOWL Werewolf Therapeutics, Inc.
7 Jan 2026
Director
Sold on a plan
11,915
$7.63K
0.5%
HOWL Werewolf Therapeutics, Inc.
6 Jan 2026
Director
Sold on a plan
40,761
$26.49K
1.7%
HOWL Werewolf Therapeutics, Inc.
5 Jan 2026
Director
Sold on a plan
18,378
$11.76K
0.7%
HOWL Werewolf Therapeutics, Inc.
2 Jan 2026
Director
Sold on a plan
18,568
$11.70K
0.7%
HOWL Werewolf Therapeutics, Inc.
31 Dec 2025
Director
Sold on a plan
24,962
$15.48K
1.0%
HOWL Werewolf Therapeutics, Inc.
30 Dec 2025
Director
Sold on a plan
34,847
$21.26K
1.4%
HOWL Werewolf Therapeutics, Inc.
29 Dec 2025
Director
Sold on a plan
108,606
$66.25K
4.1%
HOWL Werewolf Therapeutics, Inc.
26 Dec 2025
Director
Sold on a plan
35,632
$22.45K
1.3%
HOWL Werewolf Therapeutics, Inc.
24 Dec 2025
Director
Sold on a plan
16,310
$10.60K
0.6%
HOWL Werewolf Therapeutics, Inc.
23 Dec 2025
Director
Sold on a plan
71,428
$45.00K
2.6%
HOWL Werewolf Therapeutics, Inc.
22 Dec 2025
Director
Sold on a plan
59,307
$40.92K
2.1%
HOWL Werewolf Therapeutics, Inc.
17 Dec 2025
Director
Sold on a plan
9,983
$11.38K
0.4%
HOWL Werewolf Therapeutics, Inc.
16 Dec 2025
Director
Sold on a plan
14,548
$15.28K
0.5%
HOWL Werewolf Therapeutics, Inc.
15 Dec 2025
Director
Sold on a plan
23,640
$25.29K
0.8%
HOWL Werewolf Therapeutics, Inc.
12 Dec 2025
Director
Sold on a plan
17,858
$19.29K
0.6%
HOWL Werewolf Therapeutics, Inc.
11 Dec 2025
Director
Sold on a plan
28,009
$29.97K
1.0%
HOWL Werewolf Therapeutics, Inc.
10 Dec 2025
Director
Sold on a plan
37,104
$39.33K
1.2%
HOWL Werewolf Therapeutics, Inc.
9 Dec 2025
Director
Sold on a plan
44,570
$45.02K
1.5%
HOWL Werewolf Therapeutics, Inc.
8 Dec 2025
Director
Sold on a plan
34,041
$33.70K
1.1%
HOWL Werewolf Therapeutics, Inc.
5 Dec 2025
Director
Sold on a plan
16,568
$16.07K
0.5%
HOWL Werewolf Therapeutics, Inc.
4 Dec 2025
Director
Sold on a plan
53,416
$51.81K
1.7%
HOWL Werewolf Therapeutics, Inc.
3 Dec 2025
Director
Sold on a plan
36,726
$31.95K
1.2%
HOWL Werewolf Therapeutics, Inc.
2 Dec 2025
Director
Sold on a plan
38,043
$33.86K
1.2%
HOWL Werewolf Therapeutics, Inc.
1 Dec 2025
Director
Sold on a plan
39,096
$36.75K
1.2%
HOWL Werewolf Therapeutics, Inc.
28 Nov 2025
Director
Sold on a plan
13,014
$12.88K
0.4%
HOWL Werewolf Therapeutics, Inc.
26 Nov 2025
Director
Sold on a plan
38,978
$38.20K
1.2%
HOWL Werewolf Therapeutics, Inc.
25 Nov 2025
Director
Sold on a plan
27,297
$25.11K
0.8%
HOWL Werewolf Therapeutics, Inc.
24 Nov 2025
Director
Sold on a plan
56,992
$55.85K
1.7%
HOWL Werewolf Therapeutics, Inc.
21 Nov 2025
Director
Sold on a plan
41,287
$34.27K
1.2%
HOWL Werewolf Therapeutics, Inc.
20 Nov 2025
Director
Sold on a plan
26,411
$23.51K
0.8%
HOWL Werewolf Therapeutics, Inc.
19 Nov 2025
Director
Sold on a plan
42,566
$40.01K
1.2%
HOWL Werewolf Therapeutics, Inc.
18 Nov 2025
Director
Sold on a plan
33,776
$31.41K
1.0%
HOWL Werewolf Therapeutics, Inc.
17 Nov 2025
Director
Sold on a plan
36,621
$34.79K
1.0%
HOWL Werewolf Therapeutics, Inc.
14 Nov 2025
Director
Sold on a plan
39,560
$36.79K
1.1%
HOWL Werewolf Therapeutics, Inc.
13 Nov 2025
Director
Sold on a plan
58,372
$57.20K
1.6%
HOWL Werewolf Therapeutics, Inc.
12 Nov 2025
Director
Sold on a plan
26,101
$28.45K
0.7%
HOWL Werewolf Therapeutics, Inc.
11 Nov 2025
Director
Sold on a plan
35,818
$40.83K
1.0%
HOWL Werewolf Therapeutics, Inc.
10 Nov 2025
Director
Sold on a plan
31,172
$36.78K
0.8%
HOWL Werewolf Therapeutics, Inc.
7 Nov 2025
Director
Sold on a plan
43,950
$48.78K
1.2%
HOWL Werewolf Therapeutics, Inc.
6 Nov 2025
Director
Sold on a plan
34,947
$42.29K
0.9%
HOWL Werewolf Therapeutics, Inc.
5 Nov 2025
Director
Sold on a plan
30,774
$37.54K
0.8%
HOWL Werewolf Therapeutics, Inc.
4 Nov 2025
Director
Sold on a plan
90,164
$110.00K
2.3%
HOWL Werewolf Therapeutics, Inc.
3 Nov 2025
Director
Sold on a plan
60,369
$77.88K
1.5%
HOWL Werewolf Therapeutics, Inc.
31 Oct 2025
Director
Sold on a plan
73,192
$93.69K
1.8%
HOWL Werewolf Therapeutics, Inc.
30 Oct 2025
Director
Sold on a plan
55,795
$79.79K
1.4%
HOWL Werewolf Therapeutics, Inc.
29 Oct 2025
Director
Sold on a plan
86,154
$133.54K
2.0%
HOWL Werewolf Therapeutics, Inc.
28 Oct 2025
Director
Sold on a plan
44,327
$72.70K
1.0%
HOWL Werewolf Therapeutics, Inc.
27 Oct 2025
Director
Sold on a plan
46,664
$80.26K
1.1%
HOWL Werewolf Therapeutics, Inc.
27 Mar 2025
Director
Sold at will
2,425
$2.55K
0.1%
HOWL Werewolf Therapeutics, Inc.
4 May 2021
Director
Bought
150,799
$2.41M
3.6%
PCRX Pacira BioSciences, Inc.
13 Jun 2013
Director
Sold, plan not stated
20,311
$610.84K
100%
PCRX Pacira BioSciences, Inc.
12 Jun 2013
Director
Sold, plan not stated
2,435
$73.05K
10.7%
PCRX Pacira BioSciences, Inc.
3 Jun 2013
Director
Sold, plan not stated
82,072
$2.46M
9.1%
PCRX Pacira BioSciences, Inc.
31 May 2013
Director
Sold, plan not stated
9,935
$298.05K
1.1%
PCRX Pacira BioSciences, Inc.
30 May 2013
Director
Sold, plan not stated
44,582
$1.34M
4.6%
PCRX Pacira BioSciences, Inc.
29 May 2013
Director
Sold, plan not stated
20,411
$612.33K
2.1%
PCRX Pacira BioSciences, Inc.
28 May 2013
Director
Sold, plan not stated
195,117
$6.04M
16.6%
PCRX Pacira BioSciences, Inc.
22 May 2013
Director
Sold, plan not stated
7,340
$220.20K
0.6%
PCRX Pacira BioSciences, Inc.
20 May 2013
Director
Sold, plan not stated
13,550
$406.50K
1.1%
PCRX Pacira BioSciences, Inc.
24 Apr 2013
Director
Sold, plan not stated
6,303
$189.34K
0.5%
PCRX Pacira BioSciences, Inc.
23 Apr 2013
Director
Sold, plan not stated
108,115
$3.24M
8.5%
PCRX Pacira BioSciences, Inc.
15 Apr 2013
Director
Sold, plan not stated
2,575
$77.25K
0.2%
PCRX Pacira BioSciences, Inc.
12 Apr 2013
Director
Sold, plan not stated
13,416
$400.09K
1.0%
PCRX Pacira BioSciences, Inc.
18 Mar 2013
Director
Sold, plan not stated
500,000
$14.22M
17.9%
PCRX Pacira BioSciences, Inc.
11 Mar 2013
Director
Sold, plan not stated
500,000
$13.93M
15.2%
PCRX Pacira BioSciences, Inc.
21 Nov 2011
Director
Bought
461,538
$3.00M
16.3%
PCRX Pacira BioSciences, Inc.
10 Feb 2011
Director
Bought
535,714
$3.75M
23.4%
ALT Altimmune, Inc.
3 Nov 2010
10% owner
Bought
430,000
$1.51M
7.3%
ALT Altimmune, Inc.
7 Aug 2007
10% owner
Bought
125,000
$962.50K
3.7%
108 decisions on file.